GLSI Insider Trading (Greenwich LifeSciences)

Insider Ownership Percentage: 68.93%
Insider Buying (Last 12 Months): $1,122,539.36
Insider Selling (Last 12 Months): $0.00

Greenwich LifeSciences Insider Trading History Chart

This chart shows the insider buying and selling history at Greenwich LifeSciences by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Greenwich LifeSciences Share Price & Price History

Current Price: $9.98
Price Change: Price Decrease of -0.41 (-3.95%)
As of 08/16/2022 01:00 AM ET

This chart shows the closing price history over time for GLSI up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365

Greenwich LifeSciences Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
6/24/2022Snehal S. PatelCEOBuy22,535$9.13$205,744.552,706,421View SEC Filing Icon  
6/16/2022Snehal S. PatelCEOBuy8,000$7.13$57,040.002,683,886View SEC Filing Icon  
6/14/2022Snehal S. PatelCEOBuy12,000$7.91$94,920.002,675,886View SEC Filing Icon  
6/9/2022Snehal S. PatelCEOBuy4,500$10.90$49,050.001,243,453View SEC Filing Icon  
6/7/2022Snehal S. PatelCEOBuy6,000$8.55$51,300.001,238,953View SEC Filing Icon  
6/2/2022Snehal S. PatelCEOBuy6,774$7.38$49,992.121,223,703View SEC Filing Icon  
4/25/2022Frank Joseph DaughertyInsiderBuy1,000$16.25$16,250.0090,121View SEC Filing Icon  
4/21/2022Snehal S. PatelCEOBuy6,000$16.09$96,540.001,216,929View SEC Filing Icon  
4/19/2022Jaye ThompsonVPBuy500$16.74$8,370.00255,995View SEC Filing Icon  
4/19/2022Snehal S. PatelCEOBuy6,000$16.74$100,440.001,210,929View SEC Filing Icon  
2/11/2022Snehal S. PatelCEOBuy5,500$19.80$108,900.00View SEC Filing Icon  
2/4/2022Snehal S. PatelCEOBuy5,000$19.59$97,950.00View SEC Filing Icon  
1/31/2022Jaye ThompsonVPBuy500$18.47$9,235.00View SEC Filing Icon  
1/21/2022Jaye ThompsonVPBuy500$16.33$8,165.00View SEC Filing Icon  
1/21/2022Kenneth HallockDirectorBuy300$16.32$4,896.00View SEC Filing Icon  
1/18/2022Jaye ThompsonVPBuy500$18.87$9,435.00View SEC Filing Icon  
1/13/2022Jaye ThompsonVPBuy1,000$19.99$19,990.00View SEC Filing Icon  
1/3/2022Snehal S. PatelCEOBuy2,050$23.82$48,831.00View SEC Filing Icon  
12/14/2021David McWilliamsDirectorBuy200$27.56$5,512.00View SEC Filing Icon  
12/14/2021Frank Joseph DaughertyInsiderBuy1,111$26.99$29,985.89View SEC Filing Icon  
12/14/2021Snehal S. PatelCEOBuy1,840$27.17$49,992.80View SEC Filing Icon  
4/13/2021Snehal S. PatelCEOBuy2,700$36.98$99,846.001,189,539View SEC Filing Icon  
11/23/2020Frank Joseph DaughertyInsiderBuy1,000$5.10$5,100.0087,010View SEC Filing Icon  
11/19/2020Snehal S. PatelCEOBuy2,000$5.40$10,800.001,186,839View SEC Filing Icon  
See Full Table

SEC Filings (Institutional Ownership Changes) for Greenwich LifeSciences (NASDAQ:GLSI)

6.15% of Greenwich LifeSciences stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at GLSI by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

Greenwich LifeSciences Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
8/15/2022Occudo Quantitative Strategies LP23,440$0.20M0.0%N/A0.180%Search for SEC Filing on Google Icon
8/15/2022State Street Corp13,002$0.11M0.0%-80.4%0.100%Search for SEC Filing on Google Icon
8/15/2022Cubist Systematic Strategies LLC15,332$0.13M0.0%N/A0.118%Search for SEC Filing on Google Icon
8/15/2022Citadel Advisors LLC17,657$0.15M0.0%N/A0.136%Search for SEC Filing on Google Icon
8/15/2022Millennium Management LLC90,292$0.77M0.0%N/A0.695%Search for SEC Filing on Google Icon
8/13/2022Renaissance Technologies LLC105,159$0.89M0.0%N/A0.809%Search for SEC Filing on Google Icon
8/8/2022Walleye Capital LLC10,656$90K0.0%N/A0.082%Search for SEC Filing on Google Icon
6/7/2022Bank of America Corp DE6,213$0.12M0.0%+100.2%0.048%Search for SEC Filing on Google Icon
5/16/2022State Street Corp66,485$1.30M0.0%+1.8%0.513%Search for SEC Filing on Google Icon
5/13/2022Northern Trust Corp35,060$0.69M0.0%-4.3%0.271%Search for SEC Filing on Google Icon
5/13/2022Vanguard Group Inc.375,200$7.36M0.0%+150.2%2.897%Search for SEC Filing on Google Icon
5/12/2022BlackRock Inc.236,255$4.64M0.0%-0.7%1.824%Search for SEC Filing on Google Icon
4/29/2022Nisa Investment Advisors LLC7,200$0.14M0.0%N/A0.056%Search for SEC Filing on Google Icon
2/7/2022SG Americas Securities LLC4,395$0.11M0.0%N/A0.034%Search for SEC Filing on Google Icon
11/15/2021Invesco Ltd.148,087$5.79M0.0%-47.1%1.138%Search for SEC Filing on Google Icon
11/15/2021Tibra Equities Europe Ltd12,700$0.50M0.8%N/A0.098%Search for SEC Filing on Google Icon
11/12/2021OLD Mission Capital LLC7,358$0.29M0.0%N/A0.057%Search for SEC Filing on Google Icon
11/12/2021Geode Capital Management LLC56,919$2.22M0.0%+8.6%0.437%Search for SEC Filing on Google Icon
8/17/2021Invesco Ltd.280,062$12.59M0.0%N/A2.171%Search for SEC Filing on Google Icon
8/16/2021California State Teachers Retirement System5,588$0.25M0.0%N/A0.043%Search for SEC Filing on Google Icon
8/16/2021Charles Schwab Investment Management Inc.9,819$0.44M0.0%N/A0.076%Search for SEC Filing on Google Icon
8/16/2021State Street Corp50,212$2.26M0.0%N/A0.389%Search for SEC Filing on Google Icon
8/16/2021Nuveen Asset Management LLC6,392$0.29M0.0%N/A0.050%Search for SEC Filing on Google Icon
8/13/2021Northern Trust Corp12,098$0.54M0.0%N/A0.094%Search for SEC Filing on Google Icon
8/13/2021Geode Capital Management LLC52,395$2.35M0.0%+262.3%0.406%Search for SEC Filing on Google Icon
8/13/2021Vanguard Group Inc.121,418$5.46M0.0%+14.3%0.941%Search for SEC Filing on Google Icon
8/12/2021State of Wisconsin Investment Board5,200$0.23M0.0%N/A0.040%Search for SEC Filing on Google Icon
8/12/2021JPMorgan Chase & Co.4,789$0.22M0.0%N/A0.037%Search for SEC Filing on Google Icon
8/11/2021Bank of New York Mellon Corp6,664$0.30M0.0%N/A0.052%Search for SEC Filing on Google Icon
8/11/2021BlackRock Inc.217,748$9.79M0.0%+242.7%1.688%Search for SEC Filing on Google Icon
8/11/2021Deutsche Bank AG2,396$0.11M0.0%N/A0.019%Search for SEC Filing on Google Icon
8/10/2021Citigroup Inc.1,611$72K0.0%+212.8%0.012%Search for SEC Filing on Google Icon
8/2/2021New York State Common Retirement Fund3,500$0.16M0.0%N/A0.027%Search for SEC Filing on Google Icon
5/18/2021Millennium Management LLC19,450$0.66M0.0%+169.7%0.000%Search for SEC Filing on Google Icon
5/18/2021Citadel Advisors LLC7,114$0.24M0.0%N/A0.000%Search for SEC Filing on Google Icon
5/17/2021Royal Bank of Canada2,800$95K0.0%N/A0.000%Search for SEC Filing on Google Icon
5/17/2021HRT Financial LP10,952$0.37M0.0%N/A0.000%Search for SEC Filing on Google Icon
5/12/2021Geode Capital Management LLC14,463$0.49M0.0%+106.0%0.000%Search for SEC Filing on Google Icon
5/7/2021BlackRock Inc.63,540$2.17M0.0%+7.2%0.000%Search for SEC Filing on Google Icon
4/30/2021Creative Planning7,351$0.25M0.0%+4.4%0.000%Search for SEC Filing on Google Icon
4/29/2021SkyOak Wealth LLC7,405$0.29M0.1%-8.6%0.000%Search for SEC Filing on Google Icon
2/9/2021Wells Fargo & Company MN1,134$41K0.0%N/A0.000%Search for SEC Filing on Google Icon
2/5/2021BlackRock Inc.59,296$2.16M0.0%N/A0.000%Search for SEC Filing on Google Icon
2/2/2021SkyOak Wealth LLC8,104$0.30M0.1%N/A0.000%Search for SEC Filing on Google Icon
1/29/2021Creative Planning7,043$0.26M0.0%N/A0.000%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
Greenwich LifeSciences logo
Greenwich LifeSciences, Inc., a clinical stage biopharmaceutical company, focuses on the development of novel cancer immunotherapies for breast cancer and other HER2/neu-expressing cancers. Its lead product candidate is the GP2, an immunotherapy, which has completed Phase IIb clinical trial to prevent breast cancer recurrences in patients who have previously undergone surgery. The company was formerly known as Norwell, Inc. and changed its name to Greenwich LifeSciences, Inc. in March 2018. Greenwich LifeSciences, Inc. was incorporated in 2006 and is headquartered in Stafford, Texas.
Read More on Greenwich LifeSciences

Today's Range

Now: $9.98
Low: $9.82
High: $10.49

50 Day Range

MA: $8.80
Low: $7.14
High: $12.02

52 Week Range

Now: $9.98
Low: $6.82
High: $48.50

Volume

69,135 shs

Average Volume

87,616 shs

Market Capitalization

$129.74 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.57

Who are the company insiders with the largest holdings of Greenwich LifeSciences?

Greenwich LifeSciences' top insider shareholders include:
  1. Snehal Patel (CEO)
  2. Jaye Thompson (VP)
  3. Frank Joseph Daugherty (Insider)
  4. David Mcwilliams (Director)
  5. Kenneth Hallock (Director)
Learn More about top insider investors at Greenwich LifeSciences.

Who are the major institutional investors of Greenwich LifeSciences?

Greenwich LifeSciences' top institutional investors include:
  1. Renaissance Technologies LLC — 0.81%
  2. Millennium Management LLC — 0.69%
  3. Occudo Quantitative Strategies LP — 0.18%
  4. Citadel Advisors LLC — 0.14%
  5. Cubist Systematic Strategies LLC — 0.12%
  6. State Street Corp — 0.10%
Learn More about top institutional investors of Greenwich LifeSciences stock.

Which major investors are selling Greenwich LifeSciences stock?

During the last quarter, GLSI stock was sold by these institutional investors:
  1. State Street Corp

Which major investors are buying Greenwich LifeSciences stock?

Within the last quarter, GLSI stock was acquired by institutional investors including:
  1. Renaissance Technologies LLC
  2. Millennium Management LLC
  3. Occudo Quantitative Strategies LP
  4. Citadel Advisors LLC
  5. Cubist Systematic Strategies LLC
  6. Walleye Capital LLC
In the previous year, these company insiders have bought Greenwich LifeSciences stock:
  1. Snehal Patel (CEO)
  2. Jaye Thompson (VP)
  3. Frank Joseph Daugherty (Insider)
  4. David Mcwilliams (Director)
  5. Kenneth Hallock (Director)
Learn More investors buying Greenwich LifeSciences stock.